Hyaluronic Acid-based Dermal Fillers Market To Reach $11.0 Billion By 2033

Hyaluronic Acid-based Dermal Fillers Market Growth & Trends

The global hyaluronic acid-based dermal fillers market size is estimated to reach USD 11.0 billion by 2033, registering a CAGR of 10.5% from 2025 to 2033, according to a new report by Grand View Research, Inc. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.

The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.

However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

 Request a free sample copy or view report summary: Hyaluronic Acid-based Dermal Fillers Market Report

Hyaluronic Acid-based Dermal Fillers Market Report Highlights

• Based on product, the single-phase products segment held the market with the largest revenue share of 54.04% in 2024, owing to the benefits like better effectiveness & offered by these products.

• Based on application, the wrinkle removal segment led the market with the largest revenue share in 2024. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment

• North America dominated the market with the largest revenue share of in 2024. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region.

• The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region.

Hyaluronic Acid-based Dermal Fillers Market Segmentation

Grand View Research has segmented the global hyaluronic acid dermal fillers market on the basis of product, application, and region:

Hyaluronic Acid-based Dermal Fillers Product Outlook (Revenue, Million, 2021 - 2033)

• Single Phase Products

• Duplex Products

Hyaluronic Acid-based Dermal Fillers Application Outlook (Revenue, Million, 2021 - 2033)

• Wrinkle Removal

• Lip Augmentation

• Rhinoplasty

• Others

Hyaluronic Acid-based Dermal Fillers Region Outlook (Revenue, Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Russia

• Asia Pacific

  • China

  • Japan

  • South Korea

  • Thailand

  • Australia

  • Singapore

  • Malaysia

  • Taiwan

  • India

  • Vietnam

  • Philippines

• Latin America

  • Brazil

  • Argentina

  • Mexico

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Hyaluronic Acid-based Dermal Fillers Market

• Allergan

• Galderma LaboratoriesL.P.

• Merz Pharmaceuticals

• Genzyme Corporation

• Anika Therapeutics Inc.

• LG Life Sciences

• LTD (LG Chem)

• Bio plus Co. Ltd.

• Sculpt Luxury

• Dermal Fillers Ltd.

• Bioxis Pharmaceutical

• Sinclair Pharma Laboratories

• Vivacy

• Bohus Biotech AB